结构性心脏病中房颤的导管消融：综述
Catheter Ablation for Atrial Fibrillation in Structural Heart Disease: A Review.
作者信息
Brasca Francesco Maria Angelo, Menè Roberto, Perego Giovanni Battista
机构信息
Department of Cardiovascular Neural and Metabolic Sciences, San Luca Hospital, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy.
出版信息
J Clin Med. 2023 Feb 10;12(4):1431. doi: 10.3390/jcm12041431.
Abstract
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Patients with structural heart disease (SHD) are at an increased risk of developing this arrhythmia and are particularly susceptible to the deleterious hemodynamic effects it carries. In the last two decades, catheter ablation (CA) has emerged as a valuable strategy for rhythm control and is currently part of the standard care for symptomatic relief in patients with AF. Growing evidence suggests that CA of AF may have potential benefits that extend beyond symptoms. In this review, we summarize the current knowledge of this intervention on SHD patients.
摘要
心房颤动（AF）是临床实践中最常见的心律失常。患有结构性心脏病（SHD）的患者发生这种心律失常的风险增加，并且特别容易受到其带来的有害血流动力学影响。在过去二十年中，导管消融（CA）已成为一种有价值的节律控制策略，目前是房颤患者症状缓解标准治疗的一部分。越来越多的证据表明，房颤的导管消融可能具有超出症状缓解的潜在益处。在本综述中，我们总结了目前关于这种干预措施对SHD患者影响的知识。
相似文献
1
Catheter Ablation for Atrial Fibrillation in Structural Heart Disease: A Review.结构性心脏病中房颤的导管消融：综述
J Clin Med. 2023 Feb 10;12(4):1431. doi: 10.3390/jcm12041431.
2
Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: Clinical outcomes from 1STOP, a multicenter observational project.冷冻消融治疗结构性心脏病和射血分数保留的阵发性和持续性心房颤动患者：来自多中心观察项目 1STOP 的临床结果。
J Cardiol. 2019 Jul;74(1):19-26. doi: 10.1016/j.jjcc.2019.02.015. Epub 2019 Apr 1.
3
Ablation for atrial fibrillation: an evidence-based analysis.心房颤动的消融治疗：基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(7):1-63. Epub 2006 Mar 1.
4
Advanced electrophysiologic mapping systems: an evidence-based analysis.先进的电生理标测系统：基于证据的分析
Ont Health Technol Assess Ser. 2006;6(8):1-101. Epub 2006 Mar 1.
5
Impact of structural heart disease on the acute complication rate in atrial fibrillation ablation: results from the German Ablation Registry.结构性心脏病对心房颤动消融术急性并发症发生率的影响：来自德国消融登记处的结果
J Cardiovasc Electrophysiol. 2014 Mar;25(3):242-9. doi: 10.1111/jce.12319. Epub 2013 Dec 9.
6
Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: An Evaluation of Cohorts With and Without Structural Heart Disease.冷冻球囊消融术治疗阵发性心房颤动患者：伴或不伴结构性心脏病队列的评估。
Heart Lung Circ. 2020 Jul;29(7):1078-1086. doi: 10.1016/j.hlc.2019.07.020. Epub 2019 Sep 18.
7
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术：系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
8
Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control.导管消融在心房颤动治疗中的角色演变：早期且有效的节律控制
J Clin Med. 2022 Nov 21;11(22):6871. doi: 10.3390/jcm11226871.
9
[Interventional therapy of atrial fibrillation: possibilities and limitations].[心房颤动的介入治疗：可能性与局限性]
Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S48-54. doi: 10.1055/s-0030-1249209. Epub 2010 Mar 10.
10
Efficacy of catheter ablation for patients with atrial fibrillation and atrial septal defect.导管消融治疗心房颤动合并房间隔缺损患者的疗效。
J Cardiovasc Electrophysiol. 2021 Feb;32(2):279-286. doi: 10.1111/jce.14862. Epub 2021 Jan 9.
引用本文的文献
1
Efficacy and Safety of Concomitant Surgical Ablation During Mitral Valve Replacement: A Systematic Review.二尖瓣置换术中同期手术消融的疗效与安全性：一项系统评价
J Saudi Heart Assoc. 2025 Mar 27;37(2):4. doi: 10.37616/2212-5043.1426. eCollection 2025.
本文引用的文献
1
Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation.射血分数保留的心力衰竭患者接受心房颤动导管消融的结果。
Heart Rhythm O2. 2022 Jul 6;3(5):501-508. doi: 10.1016/j.hroo.2022.06.012. eCollection 2022 Oct.
2
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial.随机消融节律控制与心率控制治疗心力衰竭伴心房颤动患者的比较：来自 RAFT-AF 试验的结果。
Circulation. 2022 Jun 7;145(23):1693-1704. doi: 10.1161/CIRCULATIONAHA.121.057095. Epub 2022 Mar 22.
3
Comparing Efficacy and Safety in Catheter Ablation Strategies for Paroxysmal Atrial Fibrillation: A Network Meta-Analysis of Randomized Controlled Trials.阵发性心房颤动导管消融策略的疗效与安全性比较：随机对照试验的网状Meta分析
Diagnostics (Basel). 2022 Feb 9;12(2):433. doi: 10.3390/diagnostics12020433.
4
Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry.冷冻球囊消融治疗心力衰竭合并左心室射血分数降低或保留的心房颤动患者：Cryo AF 全球注册研究结果。
J Am Heart Assoc. 2021 Dec 21;10(24):e021323. doi: 10.1161/JAHA.121.021323. Epub 2021 Dec 10.
5
Temporal Relationship between Atrial Fibrillation and Heart Failure Development Analysis from a Nationwide Database.心房颤动与心力衰竭发展之间的时间关系：来自全国性数据库的分析
J Clin Med. 2021 Oct 30;10(21):5101. doi: 10.3390/jcm10215101.
6
Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials.不同导管消融策略治疗持续性心房颤动的疗效和安全性比较：一项随机临床试验的网络荟萃分析。
Eur Heart J Qual Care Clin Outcomes. 2022 Sep 5;8(6):619-629. doi: 10.1093/ehjqcco/qcab066.
7
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
8
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study.肥厚型心肌病患者心房颤动的导管消融：一项欧洲观察性多中心研究。
Europace. 2021 Sep 8;23(9):1409-1417. doi: 10.1093/europace/euab022.
9
Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure: The CASTLE-AF Trial.心力衰竭患者的心房颤动负荷与临床结局：CASTLE-AF试验
JACC Clin Electrophysiol. 2021 May;7(5):594-603. doi: 10.1016/j.jacep.2020.11.021. Epub 2021 Feb 24.
10
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.心房颤动心力衰竭中消融与药物治疗的比较：CABANA 试验结果。
Circulation. 2021 Apr 6;143(14):1377-1390. doi: 10.1161/CIRCULATIONAHA.120.050991. Epub 2021 Feb 8.
Zotero 插件